Evidence map›Paper›PMID 41778032›Full record

ArticleFrontiers in medicine2026

Machine learning-based prediction of intensive care unit admission in COVID-19 patients presenting with mild respiratory failure.

Bahadır Ceylan, Şule Ceylan, Oktay Olmuşçelik, Banu Karaalioğlu, Melih Akan, Meyha Şahin, Mebrule Muğlu, Selda Aydın, Ezgi Yılmaz, Rıdvan Dumlu and 7 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Bahadır CeylanDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Şule Ceylan *Department of Nuclear Medicine, University of Health Science, Gaziosmanpaşa Training ve Research Hospital, Istanbul, Türkiye.
Oktay Olmuşçelik *Department of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Banu KaraalioğluDepartment of Radiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Melih AkanDepartment of Radiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Meyha ŞahinDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Mebrule MuğluDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Selda AydınDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Ezgi YılmazDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Rıdvan DumluDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Kamil MertDepartment of Infectious Diseases and Clinical Microbiology, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Abdullah KansuDepartment of Chest Diseases, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Mustafa DügerDepartment of Chest Diseases, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Ufuk SüleymanDepartment of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Esra DemirDepartment of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
İhsan BoyacıDepartment of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.
Ali MertDepartment of Internal Medicine, Medical Faculty, Istanbul Medipol University, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Previous studies applying machine learning to predict severe respiratory failure in COVID-19 patients have shown inconsistent results due to variations in study populations and predictor variables. This study aimed to predict intensive care unit admission and identify key predictive factors. Methods: This retrospective cohort study included patients with COVID-19 who presented with mild respiratory failure, most of whom received oxygen via a mask or nasal cannula. Eight machine learning algorithms-XGBoost, support vector machines, neural networks, k-nearest neighbors, random forest, decision trees, logistic regression, and naïve Bayes-were applied to predict intensive care unit admission. Results: A total of 392 patients (63.5% male, mean age, 55.0 ± 15.3 years) were included in the study. During follow-up, 80 patients (20.4%) required intensive care unit admission. Among them, 320 (81.6%) received steroid therapy, 301 (76.8%) underwent pulse steroid therapy, and 76 (19%) had been vaccinated. The multilayer perceptron, XGBoost, and radial basis function support vector machine models achieved the best overall performance based on ROC-AUC and accuracy values (ROC-AUC: 0.75, 0.70, and 0.71; accuracy: 0.79, 0.79, and 0.79, respectively). The strongest predictors of intensive care unit admission were low lymphocyte count on the first day, as well as high age, ferritin, body mass index, Charlson Comorbidity Index, and computed tomography score. Conclusion: Machine learning algorithms can reliably predict intensive care unit admission in COVID-19 patients with mild respiratory failure. These models identified key clinical and laboratory factors that may facilitate early risk stratification and guide treatment planning.

Indexed as

COVID-19intensive care unitmachine learningprognosissteroid

Identifiers

PMID41778032
PMCPMC12951780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.